Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, Structural Genomix To Develop Protein Analysis Platform

NEW YORK, Jan 8 – Caliper and Structural Genomix have agreed to jointly develop a high throughput protein analysis system that will run on Caliper’s Microfluidics technology platform, the companies announced Monday.

In the collaboration, the companies will combine Caliper’s LabChip microfluidics technology and Structural Genomix’s high throughput X-ray crystallography methods of characterizing proteins. The combined product will put Caliper’s protein sizing and analysis assay into an automated 96-well sipper chip that can process hundreds of protein samples per day.  

This integrated microfluidics device, the companies said, will enable researchers to save the time and effort required by gel electrophoresis with a fast, automated and integrated system, designed to achieve high-level resolution to support highly precise purity analysis.

" Collaborations with leading technology developers such as Caliper will allow us to achieve our goal of bringing protein structure information to the forefront of the drug discovery process through leadership in technology development and integration,” Structural Genomix CEO Tim Harris said in a statement.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.